Skip to main content

Month: July 2021

NB Private Equity: Strong NAV Growth Drives 32% Growth in Dividend

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSStrong NAV Growth Drives 32% Growth in Dividend 15 July 2021 Highlights:Semi-annual dividend of $0.41 per share, an increase of 32% to February 2021 dividend The significant increase is driven by the Company’s 22% growth in NAV1 year to date Increase brings the annualised dividend yield on NAV to 3.0%, in line with the Company’s stated dividend policy; annualised share price yield is 4.2% based on the closing share price of £14.25 on 14 July 2021.William Maltby, Chairman, commented: “This payment represents the eighth increase in the Company’s dividend since 2013, resulting in a dividend compound annual growth rate of 8.8%. The Company’s portfolio...

Continue reading

Standard Lithium Announces Delivery of Its SiFT Lithium Carbonate Plant to El Dorado Arkansas Project Site

Figure 1One of the SiFT lithium carbonate crystallization plant modules being lowered into position at Standard Lithium’s Demonstration Plant in El Dorado, Arkansas, USA.Figure 2The final module being loaded into position, with the Company’s LiSTR DLE Plant behind. Note the climate-controlled container adjacent to the SiFT Plant, which will be used to store battery-quality lithium carbonate samples produced by the plant.EL DORADO, Ark., July 15, 2021 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE: SLI) (FRA: S5L), an innovative technology and lithium project development company today announced the delivery of its ‘SiFT’ lithium carbonate plant to the El Dorado Arkansas project site, located at the LANXESS South Plant facility. The SiFT Plant will...

Continue reading

F-Secure Half Year Report 1 January – 30 June 2021

F-Secure Corporation, Half Year Report, 15 July 2021 at 08.00 EEST F-Secure Half Year Report 1 January – 30 June 2021 Growth across all businesses – revenue up by 10% in Q2 Highlights of April-June (Q2)Revenue increased by 10% to EUR 58.2 million (53.0m) Revenue from corporate security products increased by 9% to EUR 20.2 million (18.5m) Revenue from cyber security consulting increased by 19% to EUR 11.6 million (9.7m) Revenue from consumer security increased by 6% to EUR 26.3 million (24.8m) Adjusted EBITDA was EUR 8.1 million (10.2m), 14% of revenue (19%) A strategic review resulted in items affecting comparability (IAC) of EUR 2.3 million Earnings per share (EPS) was EUR 0.01 (EUR 0.02) Cash flow from operating activities before financial items and taxes was EUR 12.9 million (11.4m)Highlights of January-June (H1)Revenue...

Continue reading

Borregaard ASA: All-time high EBITDA of NOK 416 million in the 2nd quarter

Borregaard’s operating revenues reached NOK 1,511 million (NOK 1,358 million)² in the 2nd quarter of 2021. EBITDA¹ increased to NOK 416 million (NOK 361 million), an all-time high quarterly result for the Group. BioSolutions’ result improved significantly, BioMaterials achieved a result in line with last year, whereas Fine Chemicals had a decline. The net currency impact on EBITDA was negative compared with the 2nd quarter of 2020. EBITDA in BioSolutions improved, mainly as a result of price increases and a favourable product mix, partly offset by negative net currency effects. For BioMaterials, high deliveries of speciality cellulose and an improved product mix compensated for reduced sales prices for certain grades. The decline in Fine Chemicals was mainly due to non-recurring bioethanol sales to disinfectants in the 2nd quarter last...

Continue reading

Ad hoc announcement pursuant to Art. 53 listing rules: GAM Holding AG – update on half year 2021 results

15 July 2021 Press Release Ad hoc announcement pursuant to Art. 53 listing rules: GAM Holding AG – update on half year 2021 results In accordance with its obligations under the listing rules of the SIX Swiss Exchange (article 53), GAM Holding AG is providing an update in relation to the Group’s expected results for the half year ended 30 June 2021. The Group expects to report an IFRS net loss after tax of approximately CHF 3 million for the half year of 2021. This compares to the IFRS net loss after tax of CHF 390.1 million for the half year 2020. The Group also expects to report an underlying profit before tax of approximately CHF 1 million. This compares to a CHF 2.0 million underlying loss before tax for the half year 2020. GAM will announce its 2021 half year results on 4 August 2021. Upcoming events: 4 August 2021        Half Year...

Continue reading

Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders

UPPSALA, Sweden, July 15, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of a public offering of 7,500,000 American Depositary Shares, each representing one common share of the Company (the “ADSs”), to be sold by certain selling shareholders of the Company, at a price to the public of $31.00 per ADS. In addition, certain selling shareholders have granted the underwriters a 30-day option to purchase up to 1,125,000 additional ADSs. The selling shareholders will receive all of the net proceeds from the offering and Olink will not receive any proceeds. The offering is expected to close on or about July 19, 2021, subject to the satisfaction of customary closing conditions. Goldman Sachs Bank Europe SE and Morgan Stanley & Co. LLC are acting as lead book-running...

Continue reading

Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders

UPPSALA, Sweden, July 15, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of a public offering of 7,500,000 American Depositary Shares, each representing one common share of the Company (the “ADSs”), to be sold by certain selling shareholders of the Company, at a price to the public of $31.00 per ADS. In addition, certain selling shareholders have granted the underwriters a 30-day option to purchase up to 1,125,000 additional ADSs. The selling shareholders will receive all of the net proceeds from the offering and Olink will not receive any proceeds. The offering is expected to close on or about July 19, 2021, subject to the satisfaction of customary closing conditions. Goldman Sachs Bank Europe SE and Morgan Stanley & Co. LLC are acting as lead book-running...

Continue reading

MedMira Closes New Equity Investment for Future Growth

HALIFAX, Nova Scotia, July 14, 2021 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) has closed a CAD$ 0.5 million equity investment with a Canadian arm’s length investor. The investment is strictly aimed to increase the Company’s growing operational capacity and represents fully diluted less than 1% of the total shareholding. The transaction was approved by the TSX Venture Exchange. Under the terms of deal, the investor will acquire 2,711,496 equity units at $0.18444 per unit. Each equity unit consists of one common share and one common share purchase warrant and is subject to the four month hold period. Each full warrant entitles the investor to purchase one common share of MedMira at $0.18444 per share exercisable over six months. “In anticipation of the increasing demand for our products due to the expansion of...

Continue reading

Rapid Micro Biosystems Announces Pricing of Initial Public Offering

LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the pricing of its initial public offering of 7,920,000 shares of its Class A common stock at a price to the public of $20.00 per share. All of the shares of Class A common stock are being offered by Rapid Micro. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Rapid Micro, are expected to be $158.4 million, excluding any exercise of the underwriters’ option to purchase additional shares. Rapid Micro’s Class A common stock is expected to...

Continue reading

Sera Prognostics Announces Pricing of Initial Public Offering

SALT LAKE CITY, July 14, 2021 (GLOBE NEWSWIRE) — Sera Prognostics Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of $16.00 per share. The gross proceeds to Sera from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be approximately $75.0 million. The shares are expected to begin trading on the Nasdaq Global Market on July 15, 2021 under the symbol “SERA.” The offering is expected to close on July 19, 2021, subject to customary closing conditions. In addition, Sera has granted the underwriters a 30-day option to purchase up...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.